We provide professional support in Endocrinology and Metabolic Diseases.
Endocrine and metabolic diseases span a vast range of
conditions. Together, they affect many millions of Americans and can profoundly
decrease quality of life. NIDDK supports research on many of these conditions,
including osteoporosis, cystic fibrosis, hypothyroidism, and obesity.
Osteoporosis is a disease marked by reduced bone strength and linked to aging
and fracture risk. 53 million
people in the United States either have or are at risk for osteoporosis.
Hypothyroidism, or underactive thyroid, affects about 4.6 percent of the U.S.
population age 12 and older. More than 30,000 Americans have cystic fibrosis,
an inherited disease in which salt and water cannot flow appropriately in many
critical tissues. Despite dramatic advances in treatment and life expectancy,
cystic fibrosis substantially reduces lifespan and its management is
challenging. As people are living longer with this disease, cystic fibrosis-related
diabetes has emerged as a common problem. While treatments have improved for
many of these diseases, we have much to learn about the complex interaction
between genetic and environmental factors that underlies their progression and
which may provide avenues to prevention and new therapies.
Studies of environmental factors that may alter thyroid function.
Research building on discoveries about the specific
effects of various cystic fibrosis-causing genetic mutations in order to
develop therapies that counteract the disease at a molecular level.
Studies increasing our understanding of how cells sense
and respond to available fuel and nutrient levels.
Experiments aiming to understand the molecular mechanisms
underlying autoimmune disorders such Hashimoto’s thyroiditis and Graves
disease.
Research to understand the role of parathyroid hormone in
bone health and to identify the best treatment for hyperparathyroidism, a
condition in which the parathyroid glands produce too much hormone.
Studies of bone health and fracture risk in relationship
to diseases and conditions such as obesity and weight loss surgery;
underweight; and type 1 and type 2 diabetes.
In addition, NIDDK responds to questions and
provides health information about endocrine diseases to people with
endocrine diseases and to their families, health professionals, and the public
via the NIDDK Health Information Center.
The 7-storey Private Medivia Hospital located in Çengelköy, one of the important centers of the two continents, is established on a 4000 square meter closed area and has a large car park, 26 service beds (2 suites, 24 standard), 25 incubator neonatal intensive care unit, 7 beds Our hospital with a total of 58 beds including adult intensive care unit, physical therapy and rehabilitation unit, radiology unit (MR, computed tomography, bone densitometer), sleep laboratory, endoscopy unit, 24 + 1 polyclinic room, 3 operating rooms, 2 delivery rooms, biochemistry / microbiology laboratory serves with emergency service and diagnostic units.
You will feel safe with our physician staff, nurse and assistant health personnel who can apply the preventive service and treatment approach in our hospital in the best way.
Leave your email to get all hot deals & news
which benefit you most!
©2021 All rights reserved BookingDoctors™.